Cargando…

A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains

BACKGROUND: Daptomycin is an important drug used in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection. A high dose of daptomycin is indicated for an MRSA infection with a minimum inhibitory concentration (MIC) of 1 mg/L for daptomycin. Combination therapies with daptomyci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yi-Chien, Chen, Pao-Yu, Wang, Jann-Tay, Chang, Shan-Chwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503441/ https://www.ncbi.nlm.nih.gov/pubmed/31060599 http://dx.doi.org/10.1186/s40360-019-0305-y

Ejemplares similares

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method
por: Wang, Jiun-Ling, et al.
Publicado: (2010)

A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
por: Chuang, Yu-Chung, et al.
Publicado: (2018)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis
por: Chuang, Yu-Chung, et al.
Publicado: (2014)

EVALUATION OF METHODS IN DETECTING VANCOMYCIN MIC AMONG MRSA ISOLATES AND THE CHANGES IN ACCURACY RELATED TO DIFFERENT MIC VALUES
por: Rossatto, Fernanda Cristina Possamai, et al.
Publicado: (2014)

The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort Study
por: Tseng, Tai-Chung, et al.
Publicado: (2023)

Staphylococcal Cassette Chromosome mec in MRSA, Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2007)

A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model
por: Wang, Jann-Tay, et al.
Publicado: (2022)

Daptomycin: A cyclic lipopeptide antimicrobial agent
por: Jeu, LilyAnn, et al.
Publicado: (2004)

Distribution of Staphylococcal Cassette Chromosome mec Types and Correlation with Comorbidity and Infection Type in Patients with MRSA Bacteremia
por: Wang, Jiun-Ling, et al.
Publicado: (2010)

Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
por: Barber, Katie E., et al.
Publicado: (2014)

Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost
por: Roch, Melanie, et al.
Publicado: (2017)

Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
por: Lai, Chung-Chih, et al.
Publicado: (2013)

Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus
por: Lee, Yi-Chien, et al.
Publicado: (2020)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012)

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs
por: Crompton, Jason A., et al.
Publicado: (2010)

473 Comparison of MicroScan System Prompt and Turbidity Methods for Measuring Vancomycin Minimum inhibitory concentration (MIC) against Methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 2ug/ml, the Clinical Implications and economic impact of using alternative antimicrobial agents to vancomycin for MRSA with possible MIC of 2ug/ml
por: Kamran, Amir, et al.
Publicado: (2014)

Differences in Method-Specific Vancomycin MICs and Induced Daptomycin Resistance in an Infective Endocarditis Patient
por: Lash, David Benjamin, et al.
Publicado: (2015)

Effect of a Point Mutation in mprF on Susceptibility to Daptomycin, Vancomycin, and Oxacillin in an MRSA Clinical Strain
por: Chen, Feng-Jui, et al.
Publicado: (2018)

Halogenated Pyrrolopyrimidines with Low MIC on Staphylococcus aureus and Synergistic Effects with an Antimicrobial Peptide
por: Olsen, Cecilie Elisabeth, et al.
Publicado: (2022)

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
por: Shaw, E, et al.
Publicado: (2015)

Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality
por: Hsieh, Yu-Chia, et al.
Publicado: (2016)

Antibiofilm Activity of Azadirachta indica and Catharanthus roseus and Their Synergistic Effects in Combination with Antimicrobial Agents against Fluconazole-Resistant Candida albicans Strains and MRSA
por: Neglo, David, et al.
Publicado: (2022)

Impact of Prior Healthcare-Associated Exposure on Clinical and Molecular Characterization of Methicillin-Susceptible Staphylococcus aureus Bacteremia: Results From a Retrospective Cohort Study
por: Chen, Pao-Yu, et al.
Publicado: (2015)

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
por: San-Juan, Rafael, et al.
Publicado: (2016)

Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains
por: Scull, Erin M., et al.
Publicado: (2020)

711. Molecular Epidemiology of Daptomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
por: Sundaram, Ayesha, et al.
Publicado: (2018)

The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
por: Morrisette, Taylor, et al.
Publicado: (2020)

Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
por: Liu, Wang-Da, et al.
Publicado: (2022)

Single nucleotide polymorphism leads to daptomycin resistance causing amino acid substitution—T345I in MprF of clinically isolated MRSA strains
por: Nakamura, Masaki, et al.
Publicado: (2021)

Efficiency of Antimicrobial Photodynamic Therapy with Photodithazine(®) on MSSA and MRSA Strains
por: Souza, Beatriz Müller Nunes, et al.
Publicado: (2021)

1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)
por: Thitiananpakorn, Kanate, et al.
Publicado: (2020)

Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection
por: Barlow, Ashley, et al.
Publicado: (2021)

Successful Treatment With Daptomycin of MRSA Empyema Complicated by Right-Sided Loculated Pleural Effusion Refractory to Vancomycin
por: Torjani, Ava, et al.
Publicado: (2022)

High frequency of increased triclosan MIC among CC5 MRSA and risk of misclassification of the SCCmec into types
por: Viana, Alice Slotfeldt, et al.
Publicado: (2022)

Increase of Carbapenem-Resistant Acinetobacter baumannii Infection in Acute Care Hospitals in Taiwan: Association with Hospital Antimicrobial Usage
por: Su, Chiu-Hsia, et al.
Publicado: (2012)

Predictors for vancomycin resistant Enterococcus faecium transforming from colonization to infection: a case control study
por: Chen, Pao-Yu, et al.
Publicado: (2019)

Sequence type 8 as an emerging clone of methicillin-resistant Staphylococcus aureus causing bloodstream infections in Taiwan
por: Chen, Pao-Yu, et al.
Publicado: (2021)

Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA
por: Valente, Luca G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_05q048imcbsjfehsp94608t429